Wang, Jin; Byrne, James D; Napier, Mary E et al. (2011) More effective nanomedicines through particle design. Small 7:1919-31
|
Xu, Rongzuo; Fisher, Michael; Juliano, R L (2011) Targeted albumin-based nanoparticles for delivery of amphipathic drugs. Bioconjug Chem 22:870-8
|
Alam, Md Rowshon; Ming, Xin; Fisher, Michael et al. (2011) Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA. Bioconjug Chem 22:1673-81
|
Galloway, Ashley L; Murphy, Andrew; Rolland, Jason P et al. (2011) Micromolding for the fabrication of biological microarrays. Methods Mol Biol 671:249-60
|
Juliano, Rudy L; Sunnarborg, Susan; DeSimone, Joseph et al. (2011) The Carolina Center of Cancer Nanotechnology Excellence: past accomplishments and future perspectives. Nanomedicine (Lond) 6:19-24
|
Ming, Xin; Sato, Katsuya; Juliano, Rudolph L (2011) Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes. J Control Release 153:83-92
|
Bauman, John A; Li, Shyh-Dar; Yang, Angela et al. (2010) Anti-tumor activity of splice-switching oligonucleotides. Nucleic Acids Res 38:8348-56
|
Ming, Xin; Alam, Md Rowshon; Fisher, Michael et al. (2010) Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor. Nucleic Acids Res 38:6567-76
|
Jearawiriyapaisarn, Natee; Moulton, Hong M; Sazani, Peter et al. (2010) Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers. Cardiovasc Res 85:444-53
|
Huang, Leaf; Sullenger, Bruce; Juliano, Rudy (2010) The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides. J Drug Target 18:567-74
|
Showing the most recent 10 out of 84 publications